User menu

Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).

Bibliographic reference Lambert, Julien ; Ghislain, Pierre-Dominique ; Lambert, Jo ; Cauwe, Bénédicte ; Van den Enden, Maria. Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).. In: Journal of Dermatological Treatment, , p. 1-7 (2016)
Permanent URL http://hdl.handle.net/2078.1/184940
  1. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M, Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany, 10.2340/00015555-0770
  2. Kurd Shanu Kohli, Gelfand Joel M., The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004, 10.1016/j.jaad.2008.09.022
  3. Ferrandiz C, Bordas, Garcia-Patos, Puig S, Pujol R, Smandia A, Prevalence of psoriasis in Spain (Epiderma Project: phase I), 10.1046/j.1468-3083.2001.00191.x
  4. Stern Robert S., Nijsten Tamar, Feldman Steven R., Margolis David J., Rolstad Tara, Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction, 10.1046/j.1087-0024.2003.09102.x
  5. Menter Alan, Gottlieb Alice, Feldman Steven R., Van Voorhees Abby S., Leonardi Craig L., Gordon Kenneth B., Lebwohl Mark, Koo John Y.M., Elmets Craig A., Korman Neil J., Beutner Karl R., Bhushan Reva, Guidelines of care for the management of psoriasis and psoriatic arthritis, 10.1016/j.jaad.2008.02.039
  6. Lambert J, Eur J Dermatol, 22, 231 (2012)
  7. Belinchón I., Vanaclocha F., de la Cueva-Dobao P., Coto-Segura P., Labandeira J., Herranz P., Taberner R., Juliá B., Cea-Calvo L., Puig L., Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study, 10.3109/09546634.2014.983039
  8. Poulin Yves, Papp Kim A., Wasel Norman R., Andrew Robin, Fraquelli Elisa, Bernstein Geula, Chan Daphne, A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis : Evaluation of treatment satisfaction in plaque psoriasis, 10.1111/j.1365-4632.2010.04660.x
  9. Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkilä H, Jemec G, Kragballe K, Miller I, Svensson Å, Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries, 10.2340/00015555-1485
  10. Lebwohl Mark G., Bachelez Hervé, Barker Jonathan, Girolomoni Giampiero, Kavanaugh Arthur, Langley Richard G., Paul Carle F., Puig Lluís, Reich Kristian, van de Kerkhof Peter C.M., Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey, 10.1016/j.jaad.2013.12.018
  11. Armstrong April W., Robertson Andrew D., Wu Julie, Schupp Clayton, Lebwohl Mark G., Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States : Findings From the National Psoriasis Foundation Surveys, 2003-2011, 10.1001/jamadermatol.2013.5264
  12. Mrowietz U., Kragballe K., Reich K., Spuls P., Griffiths C. E. M., Nast A., Franke J., Antoniou C., Arenberger P., Balieva F., Bylaite M., Correia O., Daudén E., Gisondi P., Iversen L., Kemény L., Lahfa M., Nijsten T., Rantanen T., Reich A., Rosenbach T., Segaert S., Smith C., Talme T., Volc-Platzer B., Yawalkar N., Definition of treatment goals for moderate to severe psoriasis: a European consensus, 10.1007/s00403-010-1080-1
  13. Mrowietz U., Implementing treatment goals for successful long-term management of psoriasis : Treatment goals for the long-term management of psoriasis, 10.1111/j.1468-3083.2011.04411.x
  14. Horn Elizabeth J., Fox Kathleen M., Patel Vaishali, Chiou Chiun-Fang, Dann Frank, Lebwohl Mark, Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey, 10.1016/j.jaad.2007.06.042
  15. Patel Vaishali, Horn Elizabeth J., Lobosco Steve J., Fox Kathleen M., Stevens Seth R., Lebwohl Mark, Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists, 10.1016/j.jaad.2008.02.048
  16. Nast Alexander, Erdmann Ricardo, Pathirana Delano, Rzany Berthold, Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination : Implementation of psoriasis guidelines, 10.1111/j.1365-2753.2008.00971.x
  17. Nast Alexander, Erdmann R., Hofelich V., Reytan N., Orawa H., Sterry W., Rzany B., Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines, 10.1007/s00403-009-0978-y
  18. Saeki Hidehisa, Imafuku Shinichi, Abe Masatoshi, Shintani Yoichi, Onozuka Daisuke, Hagihara Akihito, Katoh Norito, Murota Hiroyuki, Takeuchi Satoshi, Sugaya Makoto, Tanioka Miki, Kaneko Sakae, Masuda Koji, Hiragun Takaaki, Inomata Naoko, Kitami Yuki, Tsunemi Yuichiro, Abe Shinya, Kobayashi Miwa, Morisky Donald E., Furue Masutaka, Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients, 10.1111/1346-8138.12804
  19. Augustin M., Krüger K., Radtke M.A., Schwippl I., Reich K., Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany, 10.1159/000119415
  20. Nast Alexander, Boehncke Wolf-Henning, Mrowietz Ulrich, Ockenfels Hans-Michael, Philipp Sandra, Reich Kristian, Rosenbach Thomas, Sammain Adel, Schlaeger Martin, Sebastian Michael, Sterry Wolfram, Streit Volker, Augustin Matthias, Erdmann Ricardo, Klaus Joachim, Koza Joachim, Muller Siegrid, Orzechowski Hans-Dieter, Rosumeck Stefanie, Schmid-Ott Gerhard, Weberschock Tobias, Rzany Berthold, S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update : Preface, 10.1111/j.1610-0387.2012.07919.x
  21. Nast A., Gisondi P., Ormerod A.D., Saiag P., Smith C., Spuls P.I., Arenberger P., Bachelez H., Barker J., Dauden E., de Jong E.M., Feist E., Jacobs A., Jobling R., Kemény L., Maccarone M., Mrowietz U., Papp K.A., Paul C., Reich K., Rosumeck S., Talme T., Thio H.B., van de Kerkhof P., Werner R.N., Yawalkar N., European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC, 10.1111/jdv.13354
  22. Paul Carle F., Ho Vincent C., McGeown Claire, Christophers Enno, Schmidtmann Birgit, Guillaume Jean-Claude, Lamarque Véronique, Dubertret Louis, Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study, 10.1046/j.1523-1747.2003.12040.x
  23. Roenigk Henry H., Auerbach Robert, Maibach Howard, Weinstein Gerald, Lebwohl Mark, Methotrexate in psoriasis: Consensus conference, 10.1016/s0190-9622(98)70508-0
  24. Grossman Rachel M., Long-term Safety of Cyclosporine in the Treatment of Psoriasis, 10.1001/archderm.1996.03890300039008
  25. Levin AA, J Drugs Dermatol, 13, 848 (2014)
  26. Gniadecki R., Kragballe K., Dam T.N., Skov L., Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris : Adherence to treatment with biologics in patients with psoriasis, 10.1111/j.1365-2133.2011.10213.x
  27. Saurat J.-H., Stingl G., Dubertret L., Papp K., Langley R.G., Ortonne J.-P., Unnebrink K., Kaul M., Camez A., , Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) : Adalimumab vs. methotrexate in psoriasis, 10.1111/j.1365-2133.2007.08315.x
  28. Farhi D., Ustekinumab for the treatment of psoriasis, 10.1358/dot.2010.46.4.1464839
  29. Mrowietz U., Kragballe K., Reich K., Griffiths C.E.M., Gu Y., Wang Y., Rozzo S.J., An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals : Adalimumab efficacy in Phase III clinical trials for psoriasis, 10.1111/j.1365-2133.2012.11214.x
  30. Radtke M. A., Reich K., Spehr C., Augustin Matthias, Treatment goals in psoriasis routine care, 10.1007/s00403-014-1534-y